HAGAR Unveils New Clinical Data on Groundbreaking GWave Technology, Closing Round C Funding
TEL AVIV, Israel, August 10, 2023--HAGAR, the developer of GWave, a non-invasive continuous glucose monitoring technology that uses RF (radio frequency) waves to measure glucose levels in the blood, has announced it closed a Round C funding round of $5 million, bringing its total raised to date to $25 million. Additionally, Dr. Irl Hirsch presented HAGAR’s latest data from a proprietary study conducted at the Weizmann Institute of Science on the GWave device at the 83rd Scientific Session...
Source: yahoo.com